RETRACTION: Identification of CYP3A4 as the primary cytochrome P450 responsible for the metabolism of tandospirone by human liver microsomes (Retraction of Vol 32, Pg 131, 2007)

被引：1
|
作者：
Natsui, Kiyohi [1 ]
Mizuno, Yoshiko [1 ]
Tani, Naoko [1 ]
Yabuki, Masashi [1 ]
Komuro, Setsuko [1 ]
机构：
[1] Dainippon Sumi Tomo Pharma Co Ltd, Pharmacokinet Res Labs, Kono Hana Ku, 1-98 Kasugade Naka 3 Chome, Osaka 5540022, Japan
来源：
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS | 2019年 / 44卷 / 06期
关键词：
D O I：
10.1007/s13318-019-00585-5
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The publisher has retracted this article [1] because it is an incorrect version that was published in error: Figures 5 and 6 are missing.
引用
收藏
页码：853 / 853
页数：1
相关论文
共 50 条
  • [21] Identification of human liver cytochrome P450 enzymes responsible for the metabolism of lonafarnib (Sarasar)
    Ghosal, A
    Chowdhury, SK
    Tong, W
    Hapangama, N
    Yuan, Y
    Su, AD
    Zbaida, S
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (04) : 628 - 635
  • [22] Cytochrome P450 3A-mediated metabolism of buspirone in human liver microsomes
    Zhu, MS
    Zhao, WP
    Jimenez, H
    Zhang, DL
    Yeola, S
    Dai, RK
    Vachharajani, N
    Mitroka, J
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (04) : 500 - 507
  • [23] Metabolism of β-arteether to dihydroqinghaosu by human liver microsomes and recombinant cytochrome P450 (vol 26, pg 313, 1998)
    Grace, JM
    Aguilar, AJ
    Trotman, KM
    Peggins, JO
    Brewer, TG
    DRUG METABOLISM AND DISPOSITION, 1998, 26 (07) : 704 - 704
  • [24] Identification of cytochrome P-450 isoform(s) responsible for the metabolism of pimobendan in human liver microsomes
    Kuriya, S
    Ohmori, S
    Hino, M
    Ishii, I
    Nakamura, H
    Senda, C
    Igarashi, T
    Kiuchi, M
    Kitada, M
    DRUG METABOLISM AND DISPOSITION, 2000, 28 (01) : 73 - 78
  • [25] Allosteric Interactions in Human Cytochrome P450 CYP3A4: The Role of Phenylalanine 213 (vol 58, pg 1411, 2019)
    Denisov, Ilia G.
    Grinkova, Yelena V.
    Nandigrami, Prithviraj
    Shekhar, Mrinal
    Tajkhorshid, Emad
    Sligar, Stephen G.
    BIOCHEMISTRY, 2019, 58 (24) : 2796 - 2796
  • [26] In vitro metabolism of midazolam, triazolam, nifedipine, and testosterone by human liver microsomes and recombinant cytochromes P450: Role of CYP3A4 and CYP3A5
    Patki, KC
    von Moltke, LL
    Greenblatt, DJ
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (07) : 938 - 944
  • [27] Metabolism of (+)-Terpinen-4-ol by Cytochrome P450 Enzymes in Human Liver Microsomes
    Haigou, Risa
    Miyazawa, Mitsuo
    JOURNAL OF OLEO SCIENCE, 2012, 61 (01) : 35 - 43
  • [28] Metabolism of (+)-terpinen-4-ol by cytochrome P450 enzymes in human liver microsomes
    Department of Applied Chemistry, Faculty of Science and Engineering, Kinki University, Kowakae, Higashiosaka-shi, Osaka 577-8502, Japan
    J. Oleo Sci., 1 (35-43):
  • [29] Effects of various chemicals on metabolism of testosterone by human liver microsomes and human cytochrome P450 3A4
    Usmani, KA
    Rose, RL
    Hodgson, E
    DRUG METABOLISM REVIEWS, 2002, 34 : 179 - 179
  • [30] Changes in Drug Metabolizing Enzyme Cytochrome P450 CYP3A4 Activities Due to Polymorphisms in Human Cytochrome P450 Oxidoreductase
    Parween, Shaheena
    Udhane, Sameer S.
    Pandey, Amit V.
    FASEB JOURNAL, 2019, 33
12345